Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

• 2016 Psychotropic New Drug Update • Saklad


Psychotropic New Drug Update
1.5 CE Hour • $20 • Steve Saklad, PhamD

In this activity, Dr. Saklad describes the pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs recently marketed as well as drugs approaching the market.  Dr. Saklad covered new agents Pimavanserin, Dextromethorphan / Quindine, and Valbenazine.
 
The lecture was orginaly recorded at The University of Texas at Austin College of Pharmacy's 28th annual Psychiatric Pharmacotherapy Update, held on October 27, 2016 in Austin, Texas. 

 
Target Audience:
This course is designed for pharmacists. 
 
Program Design:
This course is presented in a lecture format, available via MP4 files, and is accompanied by PDFs of the presenter's PowerPoint slides.  A post-test and program evaluation will be completed after reviewing the  presentation.  The post-test and evaluation must be completed BEFORE October 20, 2018.
 
Note:  The video and PDF documents were developed to work on most computers, tablet, and smartphones. 
 

Fee

$20.00

CE Hours

1.50

CE Units

0.150

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
 

Requirements for CE Credit

 
ACPE Logo

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This online activity is approved for 0.15 CEUs (1.50 contact hour) of continuing education credit.  In order to receive 1.50 contact hours of CE credit, the participant must watch the videos in their entirety, complete the online post-tests, and complete the online evaluation. 

 
Technical Requirements:  Ability to view mp4 video and sound, ability to view and/or download Adobe PDF documents.  Works on most computers, smart phones, tablets, and other connected devices. 

 

 

   

Part I:  Pimavanserin Update

Objectives

  • Describe the pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs recently marketed as well as drugs approaching the market.

Speaker(s)/Author(s)

Stephen R. Saklad picture

Stephen R. Saklad, Pharm.D., BCPP
Clinical Associate Professor, UT Austin College of Pharmacy / Director, Psychiatric Pharmacy Program, UT Health Science Center San Antonio , UT Austin College of Pharmacy

Release Date: Oct 27, 2016
Credit Expiration Date: Oct 27, 2018

   

   

Part II:  Dextromethorphan / Quindine, and Valbenazine Update

Objectives

  • Describe the pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs recently marketed as well as drugs approaching the market.

Speaker(s)/Author(s)

Stephen R. Saklad picture

Stephen R. Saklad, Pharm.D., BCPP
Clinical Associate Professor, UT Austin College of Pharmacy / Director, Psychiatric Pharmacy Program, UT Health Science Center San Antonio , UT Austin College of Pharmacy

Activity Number

0067-0000-16-047-H04-P

Release Date: Oct 27, 2016
Credit Expiration Date: Oct 27, 2018

CE Hours

1.50